Papers 2004

Publications 2004

Amon W Binne  Binné  UK, Bryant H,  Jenkins PJ, Elgueta Karstegl C and Farrell PJ. Lytic cycle gene regulation of Epstein-Barr virus. Journal of Virology, 78: 13460-13469, 2004

Bartlett, N.W., Dumoutier, L., Renauld, J.-C., Kotenko, S.V., McVey, C., Lee, H.-J. & Smith, G.L. (2004). A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol 85: 1401-1412.

Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T and Lu X.  ASPP1 and ASPP2 are common activators of the p53 family members p63 and p73.  Molecular and Cellular Biology 24: 1341-1350, 2004

Brown VL, Harwood CA, Crook T, Kelsell DP and Proby CM. p16INK4a and p14ARF tumour suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.  Journal of Investigative Dermatology,122: 1284-1292, 2004.

Gillespie, S.H., Smith, G.L. & Osbourn, A. (editors) (2004). Microbe-vector interations in vector-borne disease.  Society for General Microbiology. 63, Cambridge University Press.ISBN 0 521 84312 X hardback

Gubser, C., Hué, S., Kellam, P. & Smith, G.L. (2004). Poxvirus genomes: a phylogenetic analysis. J. Gen. Virol. 85, 105-117.

Law, M. Lee, H.J., Hollinshead, M. & Smith, G.L. (2004). Yaba-like disease virus protein 144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J. Gen. Virol. 85, 1279-1290

Law, M. & Smith, G.L. (2004). Studying vaccinia virus binding and entry of the intracellular and etracellular forms of vaccinia virus.  In Methods in Molecular Biology 269, 187-204. Poxvirus Protocols S.N. Isaacs, Ed. The Humana Press Inc., New Jersey. issn: 1064-3745

O'Nions, J. and Allday M.J.  Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell derived mitogens. Journal of General Virology 85: 881-895, 2004.

O'Nions, J. and Allday M.J.  Deregulation of the cell cycle by Epstein-Barr virus (EBV). Advances in Cancer Research, Elsevier Publishers, (eds. Klein and Vande Woude) 92: 119-1186, 2004.

Slee E, Gillotin S, Bergamaschi D, Royer C, Llanos S, Ali S, Jin B, Trigiante G, Lu X. The N-terminus of a novel isoform of iASPP is required for its cytoplasmic localization. Oncogene 23: 9007-9016, 2004

Slee E, O'Connor D and Lu X. To die or not to die, how does p53 decide?  Oncogene 23: 3328-3337, 2004

Smith, G.L. & Law, M. (2004). The exit of vaccinia virus from infected cells. Virus Res. 106, 189-197

Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X and Crook T.  Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.  Oncogene 23: 3328-3337, 2004.

Yap DBS, Hsieh J-K, Zhong S, Heath V, Gusterson B, Crook T and Lu X. Ser392 phosphorylation regulates the oncogenic function of mutant p53. Cancer Research, 64: 4749-4754, 2004.